The trading price of Petros Pharmaceuticals Inc (NASDAQ:PTPI) closed lower on Tuesday, March 04, and closing at $0.09, -14.83% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $1.67 and a 52-week low of $0.09. Over the past month, the stock has lost -69.61% in value.
Petros Pharmaceuticals Inc, whose market valuation is $2.15 million at the time of this writing, is expected to release its quarterly earnings report in April. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0 per share this quarter, however they have predicted annual earnings per share of 0 for current year and 0 for next year.
On the technical side, indicators suggest PTPI has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that PTPI’s price is currently -53.33% off the SMA20 and -68.69% off the SMA50. The RSI metric on the 14-day chart is currently showing 27.08, and weekly volatility stands at 19.25%. When measured over the past 30 days, the indicator reaches 21.95%. Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s beta value is currently sitting at 1.99, while the Average True Range indicator is currently displaying 0.04.
To see how Petros Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: PTPI stock’s performance was -14.83% in the latest trading, and -95.06% in the past year.
An evaluation of the daily trading volume of Petros Pharmaceuticals Inc (NASDAQ:PTPI) indicates that the 3-month average is 6.23 million.
Currently, records show that 25.27 million of the company’s shares remain outstanding. The insiders hold 18.16% of outstanding shares, whereas institutions hold 3.85%. However, since the stock’s price has seen -78.42% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
